Vincerx Pharma, Inc. Common Stock (VINC) — Financial Flexibility Index
Vincerx Pharma, Inc. Common Stock (VINC) has a Financial Flexibility Index of -1.70x as of March 2025. Free cash flow of $-4.45 Million (operating CF $-4.45 Million minus capex $0.00) represents -2% of total liabilities ($2.62 Million). Check Vincerx Pharma, Inc. Common Stock (VINC) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vincerx Pharma, Inc. Common Stock Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Vincerx Pharma, Inc. Common Stock across 6 annual periods. For the full cash flow conversion analysis, see VINC cash generation efficiency.
Annual Financial Flexibility Index for Vincerx Pharma, Inc. Common Stock (2019–2024)
Year-by-year free cash flow to debt coverage for Vincerx Pharma, Inc. Common Stock. Explore VINC operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.95x | $-26.13 Million | $-26.13 Million | $5.28 Million | ▲ +14.5% |
| 2023 | -5.78x | $-40.45 Million | $-40.45 Million | $7.00 Million | ▼ -12.7% |
| 2022 | -5.13x | $-59.60 Million | $-59.60 Million | $11.62 Million | ▼ -216.4% |
| 2021 | -1.62x | $-28.14 Million | $-33.40 Million | $17.36 Million | ▼ -341.7% |
| 2020 | -0.37x | $-2.02 Million | $-2.28 Million | $5.50 Million | ▼ -107.2% |
| 2019 | 5.07x | $223.00K | $-35.00K | $44.00K | — |